ResMed (RMD) Reports In-Line Q1 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/13/2026
Go back to ResMed (RMD) Reports In-Line Q1 EPS
October 24, 2014 11:23 AM EDT
Piper Jaffray analyst David Clair reiterated an Overweight rating and boosted his price target on ResMed (NYSE: RMD) price target of $57.00 (from $55.00) following solid Q1 results.
Clair commented, "ResMed reported 1Q15 revenue of $380.4M, above consensus' $374.8M and our $373.3M... More
October 24, 2014 7:09 AM EDT
William Blair upgraded ResMed (NYSE: RMD) from Market Perform to Outperform.
For an analyst ratings summary and ratings history on ResMed click here. For more ratings news on ResMed click here.
Shares of ResMed closed at $47.70 yesterday.
...
More
October 23, 2014 4:21 PM EDT
ResMed (NYSE: RMD) declared a quarterly dividend of $0.28 per share, or $1.12 annualized.
The dividend will be payable on December 18, 2014, to stockholders of record on November 20, 2014, with an ex-dividend date of November 18, 2014.
The annual yield on the dividend is 2.3... More
